Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MiNK Therapeutics, Inc. - Common Stock (NQ:INKT)

10.69 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MiNK Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
MiNK Therapeutics To Present Data Update From Allogeneic iNKT Cells in Solid Tumors at SITC 2023
From MiNK Therapeutics
Via GlobeNewswire
News headline image
MiNK Therapeutics to Participate in September Investor Conferences
From MiNK Therapeutics
Via GlobeNewswire
News headline image
The Latest Analyst Ratings for MiNK Therapeutics ↗
 
Via Benzinga
News headline image
Recap: MiNK Therapeutics Q1 Earnings ↗
 
Via Benzinga
News headline image
Preview: MiNK Therapeutics's Earnings ↗
 
Via Benzinga
News headline image
MiNK Therapeutics Reports Second Quarter 2023 Results
From MiNK Therapeutics
Via GlobeNewswire
News headline image
MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update
From MiNK Therapeutics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
From MiNK Therapeutics
Via GlobeNewswire
News headline image
MiNK Presents Clinical Data on Allogeneic iNKT Cells (agenT-797) in Severe Respiratory Distress at the American Thoracic Society International Conference
From MiNK Therapeutics
Via GlobeNewswire
News headline image
MiNK's Novel FAP-CAR-iNKT Presented at ASGCT
From MiNK Therapeutics
Via GlobeNewswire
News headline image
Over $1M Bet On This Basic Materials Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗
The Dow Jones closed slightly lower on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny... 
Via Benzinga
News headline image
MiNK Therapeutics Reports Corporate Update and First Quarter 2023 Financial Results
From MiNK Therapeutics
Via GlobeNewswire
News headline image
First Foundation And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗
The Dow Jones closed lower on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
MiNK Therapeutics to Report First Quarter 2023 Corporate Update and Financial Results
From MiNK Therapeutics
Via GlobeNewswire
News headline image
MiNK Therapeutics Announces Clinical Data of Allogeneic iNKT Cells (agenT-797) in Solid Tumor Cancers at the AACR Annual Meeting
From MiNK Therapeutics
Via GlobeNewswire
News headline image
Agenus Announces Dividend of 5 Million Shares of MiNK Therapeutics
From Agenus Inc.
Via Business Wire
News headline image
MiNK Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
From MiNK Therapeutics
Via GlobeNewswire
News headline image
Earnings Scheduled For March 21, 2023 ↗
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
MiNK Therapeutics to Present Updated Clinical Data of allo-iNKT Cell Therapy in Solid Tumors at AACR Annual Meeting
From MiNK Therapeutics
Via GlobeNewswire
News headline image
MiNK Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results
From MiNK Therapeutics
Via GlobeNewswire
News headline image
MiNK Therapeutics to Participate in HC Wainwright Cell Therapy Virtual Conference
From MiNK Therapeutics
Via GlobeNewswire
News headline image
MiNK Therapeutics to Participate in B. Riley Securities Oncology Conference
From MiNK Therapeutics
Via GlobeNewswire
News headline image
Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive... 
Via Benzinga
News headline image
MiNK Therapeutics to Participate in Evercore ISI HealthCONx Conference
From MiNK Therapeutics
Via GlobeNewswire
News headline image
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday ↗
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday. 
Via Benzinga
News headline image
MiNK Presents Clinical Data at SITC 2022 Showcasing iNKT Cell Therapy Pipeline
From MiNK Therapeutics
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.